{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:39:22Z","timestamp":1781307562401,"version":"3.54.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>After initial treatment, levothyroxine (LT4) administration is necessary for thyroid cancer patients to achieve target thyroid-stimulating hormone (TSH) levels. However, the clinical efficacy of weight-based LT4 dosing has been suboptimal, highlighting the need to identify factors influencing the attainment of desired TSH levels and guide personalized treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We constructed a retrospective cohort comprising 215 patients diagnosed with thyroid cancer. The identification of factors influencing the attainment of expected TSH levels was accomplished through univariate and multivariate logistic regression analyses. Subsequently, we developed a nomogram based on these prognostic factors and performed internal validation using the bootstrap resampling method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Univariate and multivariate logistic regression analyses were conducted to analyze the clinical and demographic parameters. A nomogram was constructed using bootstrap resampling to predict the risk of TSH suppression failure, which was validated. The nomogram demonstrated moderate discrimination in estimating the risk of TSH suppression failure, with a Hosmer-Lemeshow test p-value of 0.393 and a bootstrapped calibrated C-index of 0.757 (95% CI 0.687-0.814). The calibration curve indicated good consistency of the model, and decision curve analysis suggested that the nomogram had clinical utility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Gender, preoperative serum free thyroxine (FT4) levels, T stage, and body mass index exhibit independent associations with the expected level of TSH. The established nomogram effectively predicts the risk of TSH suppression failure. Further research is warranted to investigate how these factors can be utilized in developing a personalized LT4 dosage calculator.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1422464","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:21:25Z","timestamp":1737696085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Gender, FT4 levels, T stage, and BMI as predictors of TSH levels in thyroid cancer patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Sen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/078538902321117760","article-title":"Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer","volume":"34","author":"McGriff","year":"2002","journal-title":"Ann Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/bjs.5157","article-title":"Optimization of thyroxine replacement therapy after total or near-total thyroidectomy for benign thyroid disease","volume":"93","author":"Olubowale","year":"2006","journal-title":"Br J surgery"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.1043","article-title":"Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study","volume":"31","author":"Klein Hesselink","year":"2013","journal-title":"J Clin oncology: Off J Am Soc Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1625","article-title":"Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy","volume":"95","author":"Flynn","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01986","article-title":"High prevalence of radiological vertebral fractures in women on thyroid-stimulating hormone-suppressive therapy for thyroid carcinoma","volume":"103","author":"Mazziotti","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13519","article-title":"Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer","volume":"88","author":"Pajam\u00e4ki","year":"2018","journal-title":"Clin endocrinology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0111","article-title":"A new strategy to estimate levothyroxine requirement after total thyroidectomy for benign thyroid disease","volume":"24","author":"Di Donna","year":"2014","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.12.002","article-title":"Using body mass index to predict optimal thyroid dosing after thyroidectomy","volume":"216","author":"Ojomo","year":"2013","journal-title":"J Am Coll Surgeons"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0029","article-title":"Levothyroxine replacement doses are affected by gender and weight, but not age","volume":"21","author":"Devdhar","year":"2011","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4158\/EP09257.OR","article-title":"Sex and age differences in levothyroxine dosage requirement","volume":"16","author":"Jonklaas","year":"2010","journal-title":"Endocrine practice: Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1126592","article-title":"Age-based factors modulating the required thyroxine dose to achieve thyrotropin suppression in intermediate-and high-risk papillary thyroid cancer","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin oncology: Off J Am Soc Clin Oncol"},{"key":"B14","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225842","article-title":"Metastatic lymph node ratio for predicting recurrence in medullary thyroid cancer","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12902-021-00871-x","article-title":"A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study)","volume":"21","author":"Ming","year":"2021","journal-title":"BMC endocrine Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2023.0033","article-title":"Computer-assisted levothyroxine dose selection for the treatment of postoperative hypothyroidism","volume":"33","author":"Barrio","year":"2023","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/lary.v122.4","article-title":"Levothyroxine dose following thyroidectomy is affected by more than just body weight","volume":"122","author":"Baehr","year":"2012","journal-title":"Laryngoscope"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56110586","article-title":"Hemithyroidectomy for thyroid cancer: A review","volume":"56","author":"Addasi","year":"2020","journal-title":"Medicina (Kaunas Lithuania)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0380","article-title":"Stable isotope pharmacokinetic studies provide insight into effects of age, sex, and weight on levothyroxine metabolism","volume":"28","author":"Younis","year":"2018","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03548-8","article-title":"Differentiated thyroid cancer: a focus on post-operative thyroid hormone replacement and thyrotropin suppression therapy","volume":"83","author":"Gigliotti","year":"2024","journal-title":"Endocrine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1990.258.4.E715","article-title":"Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis","volume":"258","author":"Pilo","year":"1990","journal-title":"Am J Physiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/1471-2407-14-873","article-title":"Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control study","volume":"14","author":"Cho","year":"2014","journal-title":"BMC cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/EJE-16-0007","article-title":"TSH enhancement of FT4 to FT3 conversion is age dependent","volume":"175","author":"Strich","year":"2016","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1422464\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:21:29Z","timestamp":1737696089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1422464\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":24,"alternative-id":["10.3389\/fendo.2025.1422464"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1422464","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"article-number":"1422464"}}